News

Filter

Current filters:

Biogen IdecUCB

1 to 9 of 12 results

Biogen Idec agrees $200M deal for UCB's oral MS drug

09-10-2006

Belgium's UCB and US drugmaker Biogen Idec have entered a global collaboration to jointly develop and…

AlphaBiogen IdecNystatinOralProlastinUCB

SPECTRUM week to Aug 15

22-08-2005

------------------------------------- Stock...

Akzo NobelAlpharmaAmylinAspirinAventis PharmaBayerBayerBiogen IdecCephalonRocheSanofi-AventisUCB

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top